Treatment of Complex Comorbid Psychiatric Conditions

Primary Treatment Strategy

The American College of Psychiatrists recommends prioritizing mood stabilization first with a combination of a mood stabilizer plus an atypical antipsychotic, specifically aripiprazole or quetiapine, while avoiding SSRIs until mood is stabilized in patients with comorbid bipolar 1 disorder with PTSD, anxiety, and OCD 1, 2
SSRIs should be used with caution or avoided in patients with comorbid bipolar disorder, as they may risk mood destabilization or activation, making SSRI monotherapy inappropriate 1, 2

Cognitive-behavioral therapy (CBT) with exposure and response prevention (ERP) is the preferred first-line treatment for OCD, particularly given the bipolar comorbidity where SSRIs must be used cautiously, and should consist of 10-20 sessions with psychoeducation and ERP 1, 2
The atypical antipsychotic already prescribed (quetiapine or aripiprazole) serves dual purpose for both bipolar disorder and OCD augmentation, and avoid SSRI monotherapy; if an SSRI is eventually considered, it must be combined with the mood stabilizer, with close monitoring for mood destabilization 1, 2

Quetiapine may be preferred over aripiprazole because it addresses multiple comorbidities: bipolar disorder, anxiety symptoms, and has evidence for OCD augmentation 1, 2
Aripiprazole offers a lower metabolic side effect burden compared to quetiapine, efficacy in bipolar disorder with less sedation, and should be started at 5-10 mg/day, targeting 10-15 mg/day 1, 2

Do not start with SSRI monotherapy in bipolar disorder, as this risks mood destabilization, rapid cycling, or manic switch, and the patient's previous intolerance to Prozac may reflect this phenomenon 1, 2
Do not use gabapentin as primary treatment for this complex presentation, as it lacks evidence for bipolar disorder or OCD, though it has limited evidence for anxiety 3